Published: 2018-07-23

Paronychia: incidence during Magh Mela

Upma Narain, Arun Kant, Ashok Kumar Bajaj


Background: Paronychia is one of the most common infections of the fingers and toes. Clinically, paronychia present as an acute or a chronic condition.

Methods: The retrospective study was carried out from January 2018 to February 2018 at Allahabad. Gram stain, ZN stain, KOH examination and culture were carried out in 230 cases and species identification was done by Vitek-2 system.

Results: Out of these 230 cases 142 (61.73%) presented acute paronychia, 58 (25.21%) cases of chronic paronychia and the remaining 30 cases (13.06%) did not show any growth. In the cases of acute paronychia, authors identified 53.52% Staphylococcus aures, 15.49% Staphylococcus saprophyticus, 2.82% Micrococci and 6.34% Citrobacter among aerobes while among anaerobes authors isolated 5.63% Peptococcus, 8.45% Peptostreptococcus, 3.52% Bacteroides and 4.23% Fusobacterium. Among chronic paronychia authors recorded 48.28% pure bacterial growth, 18.97% pure fungal growth, 20.69% mixed bacterial infections and 12.07% mixed bacterial and fungal infections.

Conclusions: From this study authors conclude that cold weather and humidity were the predominant and predisposing factors of the high incidence of acute paronychia. Due to very short span single pathogen was isolated from the lesions. In cases of chronic paronychia 37.76% mixed infection were also recorded which may be due to super aided infections with primary pathogen.


Acute, Bacteria, Chronic, Fungus, Paronychia

Full Text:



Relhan V, Goel K, Bansal S, Garg VK. Management of Chronic Paronychia. Indian J Dermatol. 2014;59(1):15-20.

Habif TP. Nail diseases. Clinical Dermatology: A color guide to diagnosis and therapy. 4th ed. Edinburgh, UK: Mosby; 2004:871-872.

Hay RJ, Baran R, Morre MK, Wilkinson JD. Candida onychomycosis - an evaluation of the role of Candida species in nail disease. Br J Dermatol. 1988;118:47-58.

Tosti A, Piraccini BM, Ghetti E, Colombo MD. Topical steroids versus systemic antifungal in the treatment of chronic paronychia: An open, randomized double-blind and double dummy study. J Am Acad Dermatol. 2002;47:73-6.

Narain U, Bajaj AK. Candida onychomycosis: Indian scenario. Int J Adv Med. 2016;3(3):638-42.

Narain U, Gupta A. Peritoneal Dialysis Related Candida Peritonitis: A 16-year single-centre experience. Arch Clin Microbiol. 2016;7:2.

Rockwell PG. Acute and chronic paronychia. Am Fam Physician. 2001;63:1113-6.

Leon R. Perionyxis due to Candida: clinicostatistical and mycological study. M Menerva Dermatol. 1965;40:348-56.

Esteves J. Pathogenesis and treatment of chronic paronychia. Dermatologica. 1959;119:229.

Hellier FF. Chronic Paronychia. Br J Dermatol. 1975;90:77.

Whittle CH, Moffat JL, Davis RA. Paronychia and perionychia: Aetiological aspect. Br J Dermatol. 1959;71:1-11.

Ganor S, Pumpianski R. Chronic paronychia and oral and vaginal candidal carriage. Mykosen. 1970;13:537-42.

Cherndsky MF, Dukes CO. Green nail-importance of Pseudomonas aeruginosa in Onychia. Arch Dermatol. 1963;88:548-53.

Shellow WVR, Koplon BS. Green striped nail: Chromonychia due to Pseudomona aeruginosa. Arch Dermatol. 1968;97:149.

Zuehelke RL, Taylor WR. Black nail with proteus mirabilis. Arch Dermatol. 1970;102:154.

Stone OJ, Mullins FJ. Incidence of chronic paronychia. JAMA. 1963;186:71-3.

Frain-Bell W. Chronic paronychia : Short review of 150 cases. Trans St. John's Hosp Derm Soc. 1957;38:29.

Marten RH. Chronic paronychia. BrJ Dermatol. 1959;71:422-6.